Sol Gel Technologies Ltd
SLGL4.460USD
+3.730+510.96%
收盘 05/05, 16:00（美东）报价延迟15分钟
124.24M总市值
亏损市盈率 TTM
关于 Sol Gel Technologies Ltd 公司
Sol-Gel Technologies Ltd 是一家临床阶段的皮肤病学公司。该公司专注于识别、开发和商业化用于治疗皮肤病的品牌和仿制外用药物产品。该公司提供一系列产品，包括 twins、sirs-t 和 vered。该公司设计了其专有的基于二氧化硅的微胶囊技术平台，以提高外用药物的耐受性和稳定性，同时保持其功效。外用药物通常难以在实现高功效和高耐受性之间取得平衡。其技术平台将活性成分包裹在惰性无机二氧化硅壳中，从而在活性成分和皮肤之间形成一道不明显的屏障。
公司简介
公司代码SLGL
公司名称Sol Gel Technologies Ltd
上市日期Feb 01, 2018
成立日期1997
CEO- -
员工数量34
证券类型Ordinary Share
年结日Feb 01
公司地址Golda Meir 7
城市NESS-ZIONA
上市交易所NASDAQ Capital Market Consolidated
国家Israel
邮编- -
电话97289313433
网址http://www.sol-gel.com
公司代码SLGL
上市日期Feb 01, 2018
成立日期1997
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
38.13K
+343.42%
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Ms. Yaffa Krindel
Ms. Yaffa Krindel
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
--
--
Mr. Eyal Ben-Or
Mr. Eyal Ben-Or
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Hani Lerman
Ms. Hani Lerman
Director
Director
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Mr. Nissim Bilman
Mr. Nissim Bilman
Vice President - Quality
Vice President - Quality
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
38.13K
+343.42%
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Ms. Yaffa Krindel
Ms. Yaffa Krindel
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
--
--
Mr. Eyal Ben-Or
Mr. Eyal Ben-Or
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月4日 周日
更新时间: 5月4日 周日
持股股东
股东类型
持股股东
股东统计
占比
M.Arkin Dermatology, Ltd.
64.86%
Phoenix Investment and Finances Ltd
8.87%
Migdal Insurance and Financial Holdings Ltd
4.41%
Harel Insurance Investments and Financial Services Ltd
3.30%
Arkin (Moshe)
1.37%
Other
17.19%
持股股东
股东统计
占比
M.Arkin Dermatology, Ltd.
64.86%
Phoenix Investment and Finances Ltd
8.87%
Migdal Insurance and Financial Holdings Ltd
4.41%
Harel Insurance Investments and Financial Services Ltd
3.30%
Arkin (Moshe)
1.37%
Other
17.19%
股东类型
股东统计
占比
Corporation
64.86%
Investment Advisor
13.44%
Insurance Company
4.68%
Individual Investor
1.37%
Research Firm
0.60%
Investment Advisor/Hedge Fund
0.05%
Other
15.00%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
35
2.45M
67.44%
+70.65K
2024Q4
35
23.50M
84.37%
-314.30K
2024Q3
34
23.55M
84.52%
-115.49K
2024Q2
31
25.52M
91.61%
+1.51M
2024Q1
30
23.87M
85.67%
+1.61M
2023Q4
31
22.12M
83.66%
-222.95K
2023Q3
30
22.20M
83.99%
-4.35K
2023Q2
29
22.04M
83.43%
-335.52K
2023Q1
32
22.23M
86.47%
+2.20M
2022Q4
34
20.25M
87.57%
+14.11M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
M.Arkin Dermatology, Ltd.
18.07M
64.86%
+2.00M
+12.45%
Apr 03, 2024
Phoenix Investment and Finances Ltd
2.47M
8.87%
--
--
Dec 31, 2024
Migdal Insurance and Financial Holdings Ltd
1.23M
4.41%
--
--
Dec 31, 2024
Harel Insurance Investments and Financial Services Ltd
920.33K
3.3%
--
--
Dec 31, 2024
Arkin (Moshe)
86.00K
0.31%
--
--
Apr 03, 2024
Yelin Lapidot Provident Funds Management Ltd
227.08K
0.82%
-2.10K
-0.92%
Dec 31, 2024
Morgan Stanley & Co. LLC
88.24K
0.32%
+54.88K
+164.51%
Dec 31, 2024
Menora Mivtachim Insurance Ltd.
76.11K
0.27%
--
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
39.50K
0.14%
+1.80K
+4.77%
Dec 31, 2024
查看更多
持股ETF
更新时间: 6 小时前
更新时间: 6 小时前
机构名称
占比
Invesco Raymond James SB-1 Equity ETF
0%
Invesco Raymond James SB-1 Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据